Edition:
United Kingdom

Jubilant Life Sciences Ltd (JULS.NS)

JULS.NS on National Stock Exchange of India

820.60INR
18 May 2018
Change (% chg)

Rs9.75 (+1.20%)
Prev Close
Rs810.85
Open
Rs810.85
Day's High
Rs835.75
Day's Low
Rs810.85
Volume
531,971
Avg. Vol
1,021,517
52-wk High
Rs1,039.00
52-wk Low
Rs600.00

Latest Key Developments (Source: Significant Developments)

Jubilant Life Sciences, Jubilant Stock Holding, Others File Appeals Against SEBI Adjudication Order
Wednesday, 25 Apr 2018 

April 25 (Reuters) - Jubilant Life Sciences Ltd ::CO, JUBILANT STOCK HOLDING, OTHERS FILED APPEALS BEFORE SECURITIES APPELLATE TRIBUNAL AGAINST SEBI ADJUDICATION ORDER.  Full Article

India's Jubilant Life Sciences Dec Qtr Consol Profit Up 78 Pct
Wednesday, 17 Jan 2018 

Jan 17 (Reuters) - Jubilant Life Sciences Ltd ::DEC QUARTER CONSOL NET PROFIT 2.13 BILLION RUPEES VERSUS PROFIT OF 1.19 BILLION RUPEES LAST YEAR.DEC QUARTER TOTAL REVENUE FROM OPERATIONS 20.68 BILLION RUPEES VERSUS 14.92 BILLION RUPEES LAST YEAR.  Full Article

Jubilant Life Sciences Unit Gets sNDA Approval For New Indications From USFDA For Draximage DTPA
Thursday, 28 Dec 2017 

Dec 28 (Reuters) - Jubilant Life Sciences Ltd ::SAYS UNIT GETS SNDA APPROVAL FOR NEW INDICATIONS FROM USFDA FOR DRAXIMAGE® DTPA.  Full Article

Jubilant Life Sciences Says Co Not Got Formal Environmental Nod For Gujarat Pesticide Project
Monday, 4 Dec 2017 

Dec 4 (Reuters) - Jubilant Life Sciences Ltd ::CLARIFIES ON NEWS ITEM ON CO'S PESTICIDE PROJECT IN GUJARAT GETTING GREEN PANEL NOD.SAYS CO HAS NOT GOT ANY FORMAL ENVIRONMENTAL NOD FOR GUJARAT PESTICIDE PROJECT.  Full Article

Jubilant Life Sciences says received ANDA approval for Indomethacin capsules USP
Monday, 28 Aug 2017 

Aug 28 (Reuters) - Jubilant Life Sciences Ltd ::Says Jubilant receives ANDA approval for Indomethacin capsules USP.Says drug is a nonsteroidal anti-inflammatory drug used for treatment of moderate to severe inflammation and reduce pain.  Full Article

Jubilant Life Sciences gets FDA nod for generic version of Crestor drug
Tuesday, 1 Nov 2016 

Jubilant Life Sciences Ltd :Says Jubilant Life Sciences receives ANDA approval for rosuvastatin calcium tablets.  Full Article

Jubilant Life Sciences gets ANDA approval for Darifenacin ER tablets
Thursday, 13 Oct 2016 

Jubilant Life Sciences Ltd :Says Jubilant Life Sciences receives ANDA approval for Darifenacin ER tablets.  Full Article

Jubilant Life Sciences gets Australian approval for Lyophilized kit
Wednesday, 5 Oct 2016 

Jubilant Life Sciences Ltd :Says Jubilant receives Australian approval for Lyophilized kit for the preparation of Tc 99m MAA injection.  Full Article

Jubilant Life Sciences says unit to issue high yield bonds outside India
Friday, 23 Sep 2016 

Jubilant Life Sciences Ltd : Approved the proposal to launch a benchmark offering of unsecured high yield bonds outside India by JPL .The notes are proposed to be listed on the Singapore Exchange Securities Trading Limited.  Full Article

Jubilant Life Sciences gets ANDA approval for felodipine ER tablets
Thursday, 25 Aug 2016 

Jubilant Life Sciences Ltd : Jubilant Life Sciences receives ANDA approval for Felodipine ER tablets .  Full Article

BRIEF-Jubilant Life Sciences, Jubilant Stock Holding, Others File Appeals Against SEBI Adjudication Order

* CO, JUBILANT STOCK HOLDING, OTHERS FILED APPEALS BEFORE SECURITIES APPELLATE TRIBUNAL AGAINST SEBI ADJUDICATION ORDER Source text: http://bit.ly/2JkOJp5 Further company coverage: